Correlation Between Pfizer and Blockmate Ventures

Can any of the company-specific risk be diversified away by investing in both Pfizer and Blockmate Ventures at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Blockmate Ventures into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Blockmate Ventures, you can compare the effects of market volatilities on Pfizer and Blockmate Ventures and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Blockmate Ventures. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Blockmate Ventures.

Diversification Opportunities for Pfizer and Blockmate Ventures

-0.75

Correlation Coefficient

Pfizer  Blockmate Ventures

Pay attention - limited upside

The 3 months correlation between Pfizer and Blockmate is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Blockmate Ventures in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blockmate Ventures and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Blockmate Ventures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blockmate Ventures has no effect on the direction of Pfizer i.e., Pfizer and Blockmate Ventures go up and down completely randomly.

Pair Corralation between Pfizer and Blockmate Ventures

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Blockmate Ventures. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 11.56 times less risky than Blockmate Ventures. The stock trades about -0.08 of its potential returns per unit of risk. The Blockmate Ventures is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  2.50  in Blockmate Ventures on September 4, 2024 and sell it today you would earn a total of  5.50  from holding Blockmate Ventures or generate 220.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Blockmate Ventures

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Blockmate Ventures

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Blockmate Ventures are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Blockmate Ventures reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Blockmate Ventures

The main advantage of trading using opposite Pfizer and Blockmate Ventures positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Blockmate Ventures can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blockmate Ventures will offset losses from the drop in Blockmate Ventures' long position.

The idea behind Pfizer Inc and Blockmate Ventures pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.